ESC 365
Menu
Home
Search
Events
About
ESC Platforms
Escardio.org
ESC 365
ESC eLearning
Create an account
Sign in
Back
ESC Premium Access
Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial.
Session:
Meet the Trialists - EMANATE
Topic:
Atrial fibrillation (AF)
Speaker:
Professor M. Ezekowitz (Philadelphia, US)
Event:
ESC Congress 2017
Congress Presentation
Sign in for access options
Sign in for access options
Add to my library
Like
About the speaker
Professor Michael Ezekowitz
Thomas Jefferson University Hospital, Philadelphia (United States of America)
4
presentations
0
follower
Access the full session
Meet the Trialists - EMANATE
Speakers:
Professor M. Ezekowitz
Access
Like
About the event
ESC Congress 2017
26 August - 30 August 2017
Sessions
Presentations
ESC 365 is supported by
Explore sponsored resources
Explore sponsored resources